0001213900-24-044877.txt : 20240517
0001213900-24-044877.hdr.sgml : 20240517
20240517210014
ACCESSION NUMBER: 0001213900-24-044877
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240515
FILED AS OF DATE: 20240517
DATE AS OF CHANGE: 20240517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krakaris Emmanuel
CENTRAL INDEX KEY: 0001826616
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40890
FILM NUMBER: 24962158
MAIL ADDRESS:
STREET 1: C/O AUGMEDIX, INC.
STREET 2: 1161 MISSION STREET, SUITE LL
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Augmedix, Inc.
CENTRAL INDEX KEY: 0001769804
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
ORGANIZATION NAME: 07 Trade & Services
IRS NUMBER: 833299164
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 SUTTER STREET, SUITE 1300
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 561-989-2208
MAIL ADDRESS:
STREET 1: 111 SUTTER STREET, SUITE 1300
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
FORMER COMPANY:
FORMER CONFORMED NAME: Malo Holdings Corp
DATE OF NAME CHANGE: 20190305
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0508
4
2024-05-15
0
0001769804
Augmedix, Inc.
AUGX
0001826616
Krakaris Emmanuel
C/O AUGMEDIX, INC.
111 SUTTER STREET, SUITE 1300
SAN FRANCISCO
CA
94104
1
1
0
0
PRESIDENT, CEO, AND SECRETARY
1
Common Stock
2024-05-15
4
M
0
9375
A
62426
D
Common Stock
2024-05-15
4
S
0
3528
1.19
D
58898
D
Restricted Stock Units
2024-05-15
4
M
0
9375
0.00
D
Common Stock
9375
140625
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Represents an original award of 150,000 RSUs to acquire shares of the Company's common stock. The RSU was granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. One-sixteenth (1/16th) of the RSU will vest quarterly in equal increments over four (4) years commencing on 02/15/2024, with the first one-sixteenth (1/16th) vesting on 5/15/2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Todd Holvick, Attorney-in-Fact
2024-05-17